Second Sight Medical To Be Issued Patent Titled ‘Pattern Detection and Location in a Processed Image’ On Feb. 1

https://patentcenter.uspto.gov/#!/applications/16519855 https://patentcenter.uspto.gov/#!/applications/16519855/patentTermAdjustment

byBenzinga Newsdesk

January 14, 2022

1 minute read

https://patentcenter.uspto.gov/#!/applications/16519855

https://patentcenter.uspto.gov/#!/applications/16519855/patentTermAdjustment

Sidoti & Co. Maintains Buy on DMC Glb, Lowers Price Target to $41

By Benzinga Newsdesk

Today, 9:07 PM

Sidoti & Co. analyst Marisa Hernandez maintains DMC Glb (NASDAQ:BOOM) with a Buy and lowers the price target from $55 to $41.

BOOM

Is ‘The Big Short’ Fame’s Michael Burry Indicating More Pain For Investors?

By Shivdeep Dhaliwal

Today, 9:07 PM

Physician, hedge fund manager and value investor Michael Burry has let out a tweet that appears to warn investors of further erosion in stocks.

AMZN

Celsion’s Vaccine Platform Shows Potential Against COVID-19 In Preclinical Studies

By Vandana Singh

Today, 9:07 PM

Celsion Corporation (NASDAQ:CLSN) has announced results from preclinical in vivo studies of its next-generation PLACCINE DNA vaccine platform. Data showed that…

CLSN

Ocugen Shares Spike To Recent Higher On Volume; Traders Circulate Report India’s Immunologicals Limited May Start Supplying 20M Doses Of Co. Partner, Bharat’s Covaxin By Sept.

By Benzinga Newsdesk

Today, 9:07 PM

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/iil-may-start-supplying-20-lakh-doses-of-covaxin-by-september-govt/articleshow/85010268.cms?utm_source=contentofinterest&utm_medium=tex

OCGN

Second Sight Medical To Be Issued Patent Titled ‘Pattern Detection and Location in a Processed Image’ On Feb. 1

Related Posts

Sidoti & Co. Maintains Buy on DMC Glb, Lowers Price Target to $41

Is ‘The Big Short’ Fame’s Michael Burry Indicating More Pain For Investors?

Celsion’s Vaccine Platform Shows Potential Against COVID-19 In Preclinical Studies

Ocugen Shares Spike To Recent Higher On Volume; Traders Circulate Report India’s Immunologicals Limited May Start Supplying 20M Doses Of Co. Partner, Bharat’s Covaxin By Sept.